Recombinant Human GDF6 Protein, >95%(SDS-PAGE and HPLC), high purity

Features and benefits
  • Expression System: E.coli
  • Accession #: Q6KF10
  • Protein Tag: No tag
  • Bioactivity: Fully biologically active when compared to standard. The ED₅₀ as determined by inducing alkaline phosphatase production of murine ATDC5 cells is less than 2.0 μg/ml, corresponding to a specific activity of > 500 IU/mg.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp146383
Grouped product items
SKUSizeAvailabilityPrice Qty
rp146383-10μg
10μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$58.90
rp146383-50μg
50μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$139.90
rp146383-100μg
100μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$229.90
rp146383-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,799.90

Animal Free, >95%(SDS-PAGE and HPLC), Active, E.coli, No tag, 336-455 aa

Basic Description

Product NameRecombinant Human GDF6 Protein, >95%(SDS-PAGE and HPLC), high purity
SynonymsBmp 13;BMP-13;Bmp13;Bone morphogenetic protein 13;Cartilage Derived Morphogenetic Protein 2;Cdmp 2;CDMP2;Gdf 6;GDF-6;GDF16;Gdf6;GDF6_HUMAN;Growth differentiation factor 6;Growth/differentiation factor 16;Growth/differentiation factor 6;KFM;KFS;KFS1;KFSL;K
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free, High Performance
Product Description

Purity

> 95% by SDS-PAGE and HPLC analyses.


Function

Growth factor that controls proliferation and cellular differentiation in the retina and bone formation. Plays a key role in regulating apoptosis during retinal development. Establishes dorsal-ventral positional information in the retina and controls the formation of the retinotectal map (PubMed:23307924). Required for normal formation of bones and joints in the limbs, skull, digits and axial skeleton. Plays a key role in establishing boundaries between skeletal elements during development. Regulation of GDF6 expression seems to be a mechanism for evolving species-specific changes in skeletal strucutres. Seems to positively regulates differentiation of chondrogenic tissue through the growth factor receptors subunits BMPR1A, BMPR1B, BMPR2 and ACVR2A, leading to the activation of SMAD1-SMAD5-SMAD8 complex. The regulation of chondrogenic differentiation is inhibited by NOG (PubMed:26643732). Also involved in the induction of adipogenesis from mesenchymal stem cells. This mechanism acts through the growth factor receptors subunits BMPR1A, BMPR2 and ACVR2A and the activation of SMAD1-SMAD5-SMAD8 complex and MAPK14/p38.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE&HPLC)
Purity>95%(SDS-PAGE and HPLC)
BioactivityFully biologically active when compared to standard. The ED₅₀ as determined by inducing alkaline phosphatase production of murine ATDC5 cells is less than 2.0 μg/ml, corresponding to a specific activity of > 500 IU/mg.
Endotoxin Concentration<0.1 EU/μg
Expression SystemE.coli
SpeciesHuman
Amino Acids336-455aa
SequenceTAFASRHGKRHGKKSRLRCSKKPLHVNFKELGWDDWIIAPLEYEAYHCEGVCDFPLRSHLEPTNHAIIQTLMNSMDPGSTPPSCCVPTKLTPISILYIDAGNNVVYKQYEDMVVESCGCR
Protein TagNo tag
Protein LengthFull length protein
Accession #Q6KF10
SourceRecombinant
Predicted molecular weight27.1 kDa
SDS-PAGE27.1 kDa

Images

Recombinant Human GDF6 Protein (rp146383)-Protein Bioactivity
Fully biologically active when compared to standard. The ED₅₀ as determined by inducing alkaline phosphatase production of murine ATDC5 cells is less than 2.0 μg/mL, corresponding to a specific activity of > 500 IU/mg.

Recombinant Human GDF6 Protein (rp146383) - SDS-PAGE
Recombinant Human GDF6 Protein was resolved with SDS-PAGE under reducing (R) and visualized by Coomassie® Blue staining, showing a single band at 27.1 kDa.

Product Specifications

FormLyophilized
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportio
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconst

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F0600317Certificate of AnalysisMar 26, 2024 rp146383
ZJ23F0600318Certificate of AnalysisMar 26, 2024 rp146383
ZJ23F0600319Certificate of AnalysisMar 26, 2024 rp146383

Related Documents

References

1. Asai-Coakwell M, March L, Dai XH, Duval M, Lopez I, French CR, Famulski J, De Baere E, Francis PJ, Sundaresan P et al..  (2013)  Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies..  Hum Mol Genet,  22  (7): (1432-42).  [PMID:23307924]
2. Tassabehji, May M and 12 more authors..  (2008)  Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndrome..  Human mutation,      [PMID:18425797]
3. Asai-Coakwell, Mika M and 24 more authors..  (2009)  Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes..  Human molecular genetics,    (15):   [PMID:19129173]
4. Ye, Ming M and 14 more authors..  (2010)  Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomalies..  Human molecular genetics,    (15):   [PMID:19864492]
5. Chassaing, N N and 26 more authors..  (2014)  Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia..  Clinical genetics,      [PMID:24033328]
6. Wang, Jian J and 16 more authors..  (2016)  A New Subtype of Multiple Synostoses Syndrome Is Caused by a Mutation in GDF6 That Decreases Its Sensitivity to Noggin and Enhances Its Potency as a BMP Signal..  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,      [PMID:26643732]
7. Terhal, Paulien A PA and 7 more authors..  (2018)  Further delineation of the GDF6 related multiple synostoses syndrome..  American journal of medical genetics. Part A,      [PMID:29130651]

Solution Calculators